Clinical Design Webinar

Clinical Design Technologies Ltd

Clinical Design Technologies Ltd is the manufacturer and supplier of “Urine Testing System™”, a CE Marked point of care diagnostic urine test (urinalysis) used by clinicians to monitor and screen a variety of common diseases. Urinalysis is a basic diagnostic tool. It is highly effective in indicating a number of potential medical conditions.

Testing has been used in clinical practice for decades and remains a low cost, ubiquitous test taking place in a variety of point of care settings from GP surgeries (Primary Care) to hospital wards (Secondary Care). The market is growing and is estimated to be worth circa US$1.3 billion.

Following a successful market introduction with Pilot Plant manufacture in a rented facility in St Austell, Cornwall, Clinical Design is seeking a further £2.00 million investment (EIS Investor Tax Relief available) to scale production to meet anticipated demand from European and US markets.

TAG Investment Bankers Ltd and CWIC Equity Solutions Ltd

TAG Investment Bankers is a UK company that owns TAG Funds Management (a licensed financial institution in the EU) and the TAG World Exchange ( among others in order to help fund client companies. TAG has created a unique system known as the IPSO – Initial Preferred Share Offering – a debt based funding method providing liquidity to patrons and investors alike.

TAG is pleased to work in close co-operation with CWIC Equity Solutions Ltd, a provider of sponsored and other research services into the investment and early-stage business communities.  CWIC ES Ltd’s founder Chris Wickham acts as Financing Director for TAG Investment Bankers.

Please complete the form below

Notice & Disclaimer

This page does not offer personal advice, and the information referred to on these pages is not suitable for all investors. By clicking accept or continuing to browse these pages, you confirm that you are a person falling within the following categories of an appropriately qualified investor, and are therefore exempt from the general restriction on the communication of invitations or inducements to engage in investment activity on the grounds that you are, either; a high net worth individual, a sophisticated investor, an Investment Professional or a representative of a high net worth company, trust, partnership or association. We also accept 150 retail investors per country. If you are unsure whether an investment is suitable for your circumstances we strongly encourage you to consult an FCA/SEC or other Financial Regulator in your country of residence -authorized Independent Financial Adviser before committing to any form of investment. GPDR-you accept the receipt of further information.

Required information